Retinal Debate about the utilization of intravitreal VEGF blockade agents vs PRP for cases of PDR
In this webinar Mayssam Haykalliya will debate the use of intravitreal VEGF blockade agents for PDR vs Dr. Zeina Al junaidi, MD, FICO, ABO, SBO which will debate the use of PRP for PDR. As Ameen Marashi, MD, SBO will give the final verdict of rational utilization of the commercially available VEGF blockade agents and PRP. Dr. Ameen will host Dr Noura Almansoori, which is an Emirati consultant ophthalmologist specializing in medical retina and vitreoretinal surgeries. As she will share her experience with VEGF blockade agents and PRP utilization for PDR.
Each talk in this presentation is about five to seven minutes only